IBB ETF: On Sale And Rich Option Premium To Boot

Sep. 20, 2022 7:21 PM ETiShares Biotechnology ETF (IBB)

Summary

  • IBB ETF has rarely been this oversold.
  • Volume, AUM growth and reducing short interest all point to higher prices in the IBB fund.
  • We recommend the sale of the at the money January 2024 puts which trade with a 28%+ IV.
  • Looking for a portfolio of ideas like this one? Members of Elevation Code get exclusive access to our model portfolio. Learn More »

ETF Exchange-Traded Funds investment with investor building a portfolio of financial assets on market such as stock, bonds, commodities, currencies. Capital management and finance.

NicoElNino

Intro

If we look at a long-term chart of iShares Biotechnology ETF (NASDAQ:IBB), we can see no technical damage is evident as shares of the fund continue to make higher highs and higher lows. Furthermore, as we can see from the monthly MACD indicator, which is a solid read on both trend and momentum in IBB, we see that shares have rarely been as oversold from a long-term basis as we have at present. Suffice it to say, given the sustained pattern of higher highs and higher lows in IBB up to this point, that multi-year trend-line depicted below should continue to stand firm.

IBB Higher Highs & Higher Lows

IBB Long Term Technical Chart (Stockcharts.com)

If we go to a more near-term chart of IBB, we see further evidence of a near-term bottom here. As we can see below, shares have been trading in roughly a $30 range for the best part of eight months now. However, buying volume has been on the rise meaningfully since shares bottomed in May of this year. This ties in with the more bullish trends we have seen in IBB´s assets under management in recent weeks. In fact, the assets under management ("AUM") increase of over 3% over the past month alone points to a rally in the fund before long.

Furthermore, although short interest comes in at 10.89%, the number of shares sold short continues to come down. In the last short-interest report, the number of shares sold short dropped by almost 20%. The current number of shares sold short comes in at 6.97 million shares, which again is a far more encouraging number compared to previous months.

IBB Trading Range

IBB Daily Technical Chart (Stockcharts.com)

Volatility

If we go to an implied volatility chart, we see that IBB's implied volatility (30.4%) is well above its 12-month average and is trading well above historical volatility (23.3%). ETFs trading with an implied volatility of approximately 30% may turn off traditional ETF investors who do not want to suffer unwanted drawdowns. When we take ETFs as a whole, we see that their average implied volatility comes in at approximately the 20% mark. This demonstrates the perceived risk that a long investment in IBB may have over its ETF counterparts.

How, though, can one use IBB's elevated implied volatility to both justify long exposure but also take risk off the table? What we would recommend would be the sale, for example, of the January´2024 $120 put option which presently is priced at about $1300 per put. This immediately would bring the investors' cost-basis down to the $107 level for 100 shares in IBB, which is well over 11% below IBB´s prevailing share price and also very close to underside support.

Another question is why we would recommend going out well over a year with the sale of those puts. Well, as well as the fact that the position does not need to be micro-managed (which suits long-term investors), long-term options (liquidity allowing) have higher vega (especially if one selects the at-the-money options which we have - $120 strike) over their short-term counterparts. This means that any decline in volatility (which will indeed happen as volatility is mean-reverting) will see the position respond more favorably when the eventual contraction occurs. Furthermore, longer-term options have lower gamma (how quickly delta changes), which again means much less volatility over a short-term option.

So, if we look at the setup for the trade below, we see that the position has a 70% probability of profit where the cost basis, as mentioned, is close to the $107 mark. Furthermore, the margin requirement ($1,304) really demonstrates how one can make far better returns on capital by using options over buying IBB shares outright. This is an example of using LESS risk when trading options as opposed to being long stock. We state this because by agreeing to take possession of IBB shares in 486 days' time at the $120 strike, the real cost-basis is approximately $107 ($13 less than the prevailing price per share of IBB today)

IBB Return/Risk Profile

Performance Chart IBB (Interactive Brokers)

Conclusion

The iShares Biotechnology ETF looks attractive from the long side due to its technicals (higher lows and higher highs intact), volume trends, reducing short ratio, and increasing assets under management. Furthermore, the fund's high implied volatility (also present in its longer-term options) gives long-term investors the opportunity to sell the at-the-money put options to take advantage of that elevated vega. We look forward to continued coverage.

----------------------

Elevation Code's blueprint is simple. We relentlessly look for opportunity where our aim is to put the odds in our favor in a significant way. We use options to gain leverage when applicable and we usually only enter long positions when the respective stock is trading very close to long-term (Multi-year) support. Our mission is to constantly put ourselves in positions where we have limited downside yet significant upside potential. By doing the above enough times successfully, your portfolio can only but compound its gains fast.

Join Us here

-----------------------

This article was written by

Individual Trader profile picture
17.3K Followers
Author of Elevation Code
Winning Option Trades & Idea Bank Based On Fundamental & Technical Analysis

https://individualtrader.net

My name is Jack Foley and I primarily write and research investment commentary as well as trade the markets. I'm Irish but live in Madrid, Spain with my beautiful wife and 2 children. I believe to be successful at this game, one has to have real passion for the markets and be constantly reading and researching material. From fundamentals analysis to technical analysis, options or futures, income or capital gain, long term trading or day trading, there is something for everyone in the markets depending on one's respective goals. "Starting with the end in mind" is a great mindset to start your investment career with respect to ascertaining exactly what you want to get out of the markets. Write down what you want and how quickly you want it. Therefore depending on the capital you are starting out with, you will then know what levels of risk you need to take. Whatever doubt or query you may have, I'm here to help. Shoot me an email in the contact tab and I'll come back to you as soon as possible

https://seekingalpha.com/author/individual-trader/research


Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in IBB over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.